Order Article Reprints

Calandre EP, Hidalgo-Tallon J, Molina-Barea R, Rico-Villademoros F, Molina-Hidalgo C, Garcia-Leiva JM, Carrillo-Izquierdo MD, Slim M. The Probiotic VSL#3^® Does Not Seem to Be Efficacious for the Treatment of Gastrointestinal Symptomatology of Patients with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Pharmaceuticals. 2021; 14(10):1063. https://doi.org/10.3390/ph14101063

Calandre, Elena P., Javier Hidalgo-Tallon, Rocio Molina-Barea, Fernando Rico-Villademoros, Cristina Molina-Hidalgo, Juan M. Garcia-Leiva, Maria Dolores Carrillo-Izquierdo, and Mahmoud Slim. 2021. "The Probiotic VSL#3^® Does Not Seem to Be Efficacious for the Treatment of Gastrointestinal Symptomatology of Patients with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial" Pharmaceuticals 14, no. 10: 1063. https://doi.org/10.3390/ph14101063

Calandre, E. P., Hidalgo-Tallon, J., Molina-Barea, R., Rico-Villademoros, F., Molina-Hidalgo, C., Garcia-Leiva, J. M., Carrillo-Izquierdo, M. D., & Slim, M. (2021). The Probiotic VSL#3^® Does Not Seem to Be Efficacious for the Treatment of Gastrointestinal Symptomatology of Patients with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Pharmaceuticals, 14(10), 1063. https://doi.org/10.3390/ph14101063